Many studies may offer the following:. AcurianHealth is your guide for getting connected to clinical research studies. Studies may offer: No-cost study-related care Access to treatments under development Possible compensation See if you qualify! Studies may offer: No-cost study related-care Access to treatments under development Possible compensation See if you qualify! MDD may lead to changes in in sleep patterns, too. Right now, researchers are evaluating oral study medications that work with your current antidepressant medication to help treat unresolved symptoms of major depression.
The study medications being evaluated have the potential to be an important option for the treatment of depression. Take the next step to see if you qualify for local research studies for people with major depression. AcurianHealth helps connect people with research studies that offer treatment under development.
Since , AcurianHealth has referred 1 million study candidates to studies in 70 countries. Major depression can make every day feel overwhelming. We have a comprehensive clinical trials database that we use to locate the best clinical trials near you. Clinical trials, by definition , are the final stage of research studies that are meant to determine if a new medication, device, or method of treatment is safe and effective in humans.
They are conducted after the researchers finish preclinical studies—testing the drug in labs and on animals. Clinical trials consist of four phases, and each phase has a specific purpose. They are usually paid for healthy volunteers during the first and second phase—the early clinical trial phases. When the clinical study reaches the fourth phase, the Food and Drug Administration FDA checks the results and decides whether the drug is ready for manufacture. Universities, medical centers, and pharmaceutical companies are usually the sponsors of clinical trials.
Deciding to participate in a clinical trial is a serious step, and before making it, you should consult your doctor. Some of the reasons that encourage people to participate in clinical trials are:. We can do so by helping you find the highest-paid clinical trials near you within our database of clinical trials. You can access DoNotPay in any web browser and apply for as many clinical trials as you like.
We will send an email to the researchers immediately and increase your chances of getting in. They can shorten trial timelines, but there is also an incremental cost to use the software, and the possibilities they open up are themselves costly. Similarly, identifying patients around the country would speed up trial recruitment, but would also require the recruitment and funding of many more clinical trial sites.
These sites themselves can have logistical hurdles, especially for novel therapeutics that are very difficult to produce, ship, and administer correctly. Indeed, Kymriah, the product cited in your first paragraph, is only available at a select number of centers across the country, so finding incremental patients in, say, Nebraska may not have helped [1].
Where do they get their data on 17 million people and their health conditions? Are there privacy concerns associated with this that could have the potential for public backlash e.
Most importantly, do they have a repeatable and scalable way to continue getting data on new patients, or is this a static data set? Accessed November 30, Courtney — this is such an interesting and well-articulated piece on the challenges and opportunities to transform clinical trial recruitment through digital platforms like that of Acurian. I had no idea that this step in the drug development supply chain was so inefficient and costly and I can only assume that the costs incurred in recruitment often trickle down to the final price of the drug, impacting patient access.
I worry that Acurian will need to invest significantly to make this shift happen which could be problematic from a business sustainability perspective and create space for competitors to enter. Ultimately, Acurian will need to differentiate itself on its proprietary digital capabilities — how can it capture the most patient data and use it in a way that generates more value for drug developers than its competitors can?
0コメント